<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03895008</url>
  </required_header>
  <id_info>
    <org_study_id>AHQU-2019001</org_study_id>
    <nct_id>NCT03895008</nct_id>
  </id_info>
  <brief_title>Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.</brief_title>
  <official_title>Comparing the Stage-for-Stage Prognosis of Patients With Cardia and Non-cardia Gastric Cancer After Operation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Affiliated Hospital of Qinghai University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Qinghai People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Affiliated Hospital of Qinghai University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To comparing the stage-for-stage prognosis of patients with cardia and non-cardia gastric
      cancer after operation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to compare the stage-for-stage prognosis of patients with cardia and
      non-cardia gastric cancer after operation.In this study, patients with cardiac and
      non-cardiac gastric cancer who undergo radical resection from January 2019 to December 2024
      will be included. We will follow up the patient's progression, recurrence time and survival
      time.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 8, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disease Free Survival（DFS）</measure>
    <time_frame>5 years</time_frame>
    <description>The time from the primary operation to disease recurrence or death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival(OS)</measure>
    <time_frame>5 years</time_frame>
    <description>OS is defined as the time from the end of radical surgery to death for any reason or at the last follow-up.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Cardia gastric cancer</arm_group_label>
    <description>Cardiac gastric cancer is defined as a cancer center lies arising 2-5 cm from the gastric mucosa distal to the esophagogastric junction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-cardia gastric cancer</arm_group_label>
    <description>Non-cardia gastric cancer is defined as tumors originated from the gastric mucosa distal to the cardia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardia and Non-cardia gastric cancer</intervention_name>
    <description>We classify gastric cancer into cardia gastric cancer and non-cardia gastric cancer.</description>
    <arm_group_label>Cardia gastric cancer</arm_group_label>
    <arm_group_label>Non-cardia gastric cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        gastric cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Histopathology or cytopathology proven cardia or non-cardia gastric cancer;

          2. Operable gastric cancer patients: primary lesions can be completely excision, no
             distant metastasis;

          3. Life expectancy of at least 6 months;

          4. ECOG（Eastern Cooperative Oncology Group ） score 0-1;

          5. Age: 18~80 years old;

          6. Normal hemodynamic indices before the recruitment (including blood cell count and
             liver/kidney function).

             For example: WBC（White blood cell count ）&gt;4.0×109/L; NEU（Neutrophils）&gt;1.5×109/L;
             PLT（Platelet）&gt;100×109/L;

          7. Roughly normal cardiopulmonary function: No coronary heart disease, myocardial
             infarction, pulmonary heart disease, refractory hypertension;

          8. Not concomitant with other uncontrollable benign diseases before the recruitment;

          9. Voluntarily signed the informed consent.

        Exclusion Criteria:

          1. Advanced gastric cancer patients with distant metastasis and inoperable ;

          2. Pregnant or lactating women;

          3. Patients who have no desire to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiuda Zhao, M.D.</last_name>
    <phone>+869716162732</phone>
    <email>jiudazhao@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Second Hospital of Lanzhou University</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enxi Li</last_name>
      <phone>15809317472</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Qinghai University</name>
      <address>
        <city>Xining</city>
        <state>Qinghai</state>
        <zip>810000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiuda Zhao, M.D.</last_name>
      <phone>+869716162732</phone>
      <email>jiudazhao@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Qinghai Province</name>
      <address>
        <city>Xining</city>
        <state>Qinghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Kan, M.D</last_name>
      <phone>+8613897584590</phone>
      <email>kanying1208@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 28, 2019</study_first_submitted>
  <study_first_submitted_qc>March 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2019</study_first_posted>
  <last_update_submitted>July 2, 2019</last_update_submitted>
  <last_update_submitted_qc>July 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Affiliated Hospital of Qinghai University</investigator_affiliation>
    <investigator_full_name>Jiuda Zhao</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cardia gastric cancer</keyword>
  <keyword>Non-cardia gastric cancer</keyword>
  <keyword>Resection</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

